These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

172 related items for PubMed ID: 4729722

  • 41. Haemodynamic effects of treatment and withdrawal of spironolactone in essential hypertension.
    Falch DK, Johansson R, Odegaard AE, Norman N.
    Scand J Clin Lab Invest; 1979 Apr; 39(2):159-65. PubMed ID: 523964
    [Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43. Hypertension and severe hyperkalaemia associated with suppression of renin and aldosterone and completely reversed by dietary sodium restriction.
    Gordon RD, Geddes RA, Pawsey CG, O'Halloran MW.
    Australas Ann Med; 1970 Nov; 19(4):287-94. PubMed ID: 5490655
    [No Abstract] [Full Text] [Related]

  • 44. [Long-term minoxidil therapy: renin, aldosterone, noradrenaline and the need for beta blockers].
    Jaeger P, Brunner HR, Turini GA, Jéquier E, Ferguson RK, Gavras H.
    Schweiz Med Wochenschr; 1978 Nov 04; 108(44):1707-9. PubMed ID: 715407
    [Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46. Initial potassium loss and hypokalaemia during chlorthalidone administration in patients with essential hypertension: the influence of dietary sodium restriction.
    Landmann-Suter R, Struyvenberg A.
    Eur J Clin Invest; 1978 Jun 04; 8(3):155-64. PubMed ID: 28952
    [Abstract] [Full Text] [Related]

  • 47. Renin profiling in hypertension and its use in treatment with propranolol and chlorthalidone.
    Woods JW, Pittman AW, Pulliam CC, Werk EE, Waider W, Allen CA.
    N Engl J Med; 1976 May 20; 294(21):1137-43. PubMed ID: 772425
    [Abstract] [Full Text] [Related]

  • 48. [Spironolactone-induced changes of the renin-angiotensin-aldosterone system and blood pressure lowering in essential hypertension].
    Furrer J, Vetter W, Nussberger J, Beckerhoff R, Siegenthaler W.
    Verh Dtsch Ges Kreislaufforsch; 1977 May 20; 43():235-6. PubMed ID: 349929
    [No Abstract] [Full Text] [Related]

  • 49. Plasma renin activity does not predict the antihypertensive efficacy of chlorthalidone.
    Salvetti A, Pedrinelli R, Bartolomei G, Cagianelli MA, Cinotti G, Innocenti P, Loni C, Saba G, Saba P, Papi L.
    Eur J Clin Pharmacol; 1987 May 20; 33(3):221-6. PubMed ID: 3319646
    [Abstract] [Full Text] [Related]

  • 50. Disparate patterns of aldosterone response during diuretic treatment of hypertension.
    Weber MA, Drayer JI, Rev A, Laragh JH.
    Ann Intern Med; 1977 Nov 20; 87(5):558-63. PubMed ID: 921083
    [Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52. Effect of propranolol on elevated arterial blood pressure.
    Richardson DW, Freund J, Gear AS, Mauck HP, Preston LW.
    Circulation; 1968 Apr 20; 37(4):534-42. PubMed ID: 4870102
    [No Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54. Reduced response of plasma aldosterone to acute ACTH stimulation during long-term treatment with spironolactone in essential hypertension.
    Kim KS, Morimoto S, Uchida K, Miyamori I, Miyamoto M, Takeda R.
    Horm Res; 1979 Apr 20; 11(1):4-11. PubMed ID: 225255
    [Abstract] [Full Text] [Related]

  • 55. Effect of spironolactone in hypertensive patients.
    Crane MG, Harris JJ.
    Am J Med Sci; 1970 Dec 20; 260(6):311-30. PubMed ID: 5511395
    [No Abstract] [Full Text] [Related]

  • 56. Low-renin hypertension. Restoration of normotension and renin responsiveness.
    Spark RF, O'Hare CM, Regan RM.
    Arch Intern Med; 1974 Feb 20; 133(2):205-11. PubMed ID: 4591266
    [No Abstract] [Full Text] [Related]

  • 57. Intrarenal sodium handling during chronic spironolactone treatment.
    Roos JC, Dorhout Mees EJ, Koomans HA, Boer P.
    Nephron; 1984 Feb 20; 38(4):226-32. PubMed ID: 6514071
    [Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59. [Pathogenesis of essential hypertension with suppressed plasma renin activity].
    Uchida K.
    Nihon Naibunpi Gakkai Zasshi; 1972 Dec 20; 48(9):674-84. PubMed ID: 4675750
    [No Abstract] [Full Text] [Related]

  • 60. Renin subgroups in essential hypertension. Further analysis of their pathophysiological and epidemiological characteristics.
    Brunner HR, Sealey JE, Laragh JH.
    Circ Res; 1973 May 05; 32():Suppl 1:99-105. PubMed ID: 4712516
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.